Pregnancy biomarkers as early indicators of cardiovascular risk: a discussion article.

Giulia Renda¹, Daniele Falco¹, Sabina Gallina¹, Anna Vittoria Mattioli²

¹Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.

²Department for Quality of Life Sciences, University of Bologna - Alma Mater Studiorum, Bologna, Italy.

PubMed DOI

Abstract

Pregnancy provides a unique opportunity for early cardiovascular prevention by revealing maternal vascular and cardiometabolic vulnerability. Placental growth factor (PlGF), uterine artery Doppler and emerging inflammatory biomarkers may improve the identification of placental dysfunction and adverse pregnancy outcomes. However, their ability to predict long-term maternal cardiovascular risk remai…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.